Mass General Cancer Center Classical Hematology Review & ASH Highlights

Please note, access to symposium recordings is included with registration.
Access will be available for 30 days post event.

The Mass General Cancer Center Classical Hematology Review and ASH Highlights will be an interactive, virtual CME program highlighting state-of-the-art care for patients with hematologic diseases. This is a unique course, focused solely on classical hematology and the intricacies that come along with these diseases. Presentations will provide a combination of consultative case studies, approaches to patient care with various abnormalities, and the latest science and treatment paradigms from the 2022 ASH Meeting. There will be designated time in each section for a moderated Q&A, encouraging interaction between the audience and faculty.

Target audience

This activity is intended for Physicians, Nurses, Physician Assistants and other members of the healthcare team across the United States.

Learning objectives

Upon completion of this activity, participants will be able to:

• Identify and initiate management for a wide spectrum of hematology diseases
• Recognize emergent hematologic processes
• Operate appropriate diagnostic studies and initiate therapy

Registration instructions

Cancellation Policy:

Registrations cancelled on or before January 31, 2023 will be refunded, less a $20 administrative fee. Registrations cancelled after January 31, 2023 will not be refunded.

Additional information

Massachusetts General Hospital Cancer Center & Mass General Brigham

Faculty credentials

Annemarie Fogerty, MD – Course Director
Assistant Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Cancer Center

Hanny Al-Samkari, MD
Classical Hematologist and Clinical Investigator
Co-Director, Hereditary Hemorrhagic Telangiectasia Center
Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School

Sharl Azar, MD
Medical Director, Comprehensive Sickle Cell Disease Treatment Center
Massachusetts General Hospital Cancer Center

Pavan Bendapudi, MD
MGH Division of Hematology and Blood Transfusion Service
Assistant Professor of Medicine, Harvard Medical School

Larissa Bornikova, MD
Instructor in Medicine, Hematology-Oncology, Harvard Medical School
Massachusetts General Hospital Cancer Center

Jonathan Carlson, MD, PhD
Physician Investigator (Cl), Mass General Cancer Center, Mass General Research Institute
Instructor in Medicine, Harvard Medical School
Assistant In Medicine, Hematology-Oncology, Massachusetts General Hospital

Sunny Dzik, MD
Associate Pathologist, Massachusetts General Hospital
Associate Professor of Pathology, Harvard Medical School

Katayoon Goodarzi, MD
Physician Investigator, Mass General Research Institute
Instructor in Medicine, Harvard Medical School
Assistant In Medicine, Massachusetts General Hospital Cancer Center

Rebecca Karp, MD
Co-Founder and Co-Director, Porphyria Center
Assistant Professor, Harvard Medical School
Division of Hematology, Massachusetts General Hospital Cancer Center

David Kuter, MD, DPhil
Hematology Program Director, Massachusetts General Hospital
Professor of Medicine, Harvard Medical School

Rachel Rosovsky, MD, MPH
Director, Thrombosis Research – Division of Hematology, Massachusetts General Hospital Cancer Center
Co-Chair of Thrombosis Committee, Massachusetts General Hospital
Associate Professor, Harvard Medical School

David Sykes, MD, PhD
Assistant Professor, Harvard Medical School
Massachusetts General Hospital Cancer center

Anem Waheed, MD, MPH
Instructor in Medicine, Massachusetts General Hospital Cancer Center

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credits^TM
Mass General Brigham designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
Mass General Brigham designates this activity for 7.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity

PAs
Mass General Brigham has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Program